Prevalence of Shigellosis in Pediatric Diarrheal Patients in Chattogram, Bangladesh: A Molecular Based Approach
Preprint
Abstract
Shigella a gram negative, non-motile bacillus, is the primary causative agent of the infectious disease shigellosis, which kills 1.1 million people worldwide every year. The children under the age of five are primarily the victims of this disease. This study has been conducted to assess the prevalence of shigellosis through selective plating, biochemical test and conventional PCR assays, where the samples were collected from suspected diarrheoal patients. Invasive plasmid antigen H ( ipaH ) and O-antigenic rfc gene were used to identify Shigella spp . and S. flexneri respectively. For validation of these identification, PCR product of ipaH gene of a sample (Shigella flexneri MZS 191) has been sequenced and submitted to NCBI database (GenBank accession no- MW774908.1 ). Further this strain has been used as positive control. Out of 204, around 14.2% (n=29) pediatric diarrheoal cases were screened as shigellosis. Another interesting finding was that most of shigellosis affected children were 7 months to 1 year. The significance of this study lies in the analyses of the prevalence and the molecular identification of Shigella spp . and S. flexneri that can be utilized in improving the accurate identification and the treatment of the most severe and alarming shigellosis.Keywords
This publication has 16 references indexed in Scilit:
- Screening and Identification of Antibiotic Resistant Gene int1 in Coliforms Isolated From Drinking WaterAir, Soil and Water Research, 2022
- Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017The Lancet Infectious Diseases, 2020
- Shigella-mediated immunosuppression in the human gut: subversion extends from innate to adaptive immune responsesHuman Vaccines & Immunotherapeutics, 2019
- Shifting national surveillance of Shigella infections toward geno‐serotyping by the development of a tailored Luminex assay and NGS workflowMicrobiologyopen, 2019
- A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and childrenHuman Vaccines & Immunotherapeutics, 2019
- A murine model of diarrhea, growth impairment and metabolic disturbances withShigella flexneriinfection and the role of zinc deficiencyGut Microbes, 2019
- The synthesis of OspD3 (ShET2) inShigella flexneriis independent of OspC1Gut Microbes, 2016
- A Pentaplex PCR Assay for the Detection and Differentiation ofShigellaSpeciesBioMed Research International, 2013
- Changing species distribution and antimicrobial susceptibility pattern ofShigellaover a 29-year period (1980–2008)Epidemiology and Infection, 2010
- Shigella flexneriinfection: pathogenesis and vaccine developmentFEMS Microbiology Reviews, 2004